查詢結果分析
來源資料
相關文獻
- 精神藥物減藥計畫於失智症激動症狀之治療
- 以行動科技為基礎的互動式高齡失智者治療與照護環境之創新設計
- 失智症的預防與非藥物治療的新契機
- Second-Generation Antipsychotics for Treatment of Behavioral and Psychological Symptoms in Dementia: Indication or Contraindication
- A Retrospective Comparison Study of Risperidone and Sulpiride for Outpatients with Dementia
- 探討日照中心活動課程設計與降低失智者躁動之關聯性
- 非藥物治療於居家失智長者之應用
- 陪伴型機器人使用者經驗評估--以智慧居家機器人Zenbo為例
- 失智者之居家職能治療
- Uterine Myoma after Cessation of Gonadotropin-Releasing Hormone Agonist: Ultrasound and Histopathologic Findings
頁籤選單縮合
| 題 名 | 精神藥物減藥計畫於失智症激動症狀之治療=Psychotropic Medications Reduction Programs for Managing Agitation in Dementia |
|---|---|
| 作 者 | 楊焯翔; 黃宗正; | 書刊名 | 臺灣醫學 |
| 卷 期 | 28:2 2024.03[民113.03] |
| 頁 次 | 頁239-246 |
| 分類號 | 415.934 |
| 關鍵詞 | 失智症; 激動; 抗精神病劑; 精神作用藥品; 以個人為中心的照顧; 非藥物治療; Dementia; Agitation; Antipsychotic; Psychotropic; Person-centered care; Non-pharmacological intervention; |
| 語 文 | 中文(Chinese) |
| DOI | 10.6320/FJM.202403_28(2).0013 |
| 中文摘要 | 失智症病人高達9成會出現行為問題,激動症狀是最常見的行為症狀,這些症狀不僅造成病人及照顧者困擾,還會加速認知及生活功能退步,使病人更早住進機構,增加死亡的風險。可惜,激動症狀的藥物治療常伴隨各種不良反應,因此歐美各國都提醒醫師謹慎處方抗精神病劑,但減少抗精神病劑,替代的處方藥物可能會隨之增加。近年各國在護理之家嘗試減少使用精神作用藥品,不同的介入模式結果也不盡相同。有較多證據支持,比起單純的藥物回顧,採用以個人為中心的多種非藥物治療方法效果會更好。本文將回顧上述議題,再依據最新的證據與指引提出建議,期盼對臨床照顧有所助益。 |
| 英文摘要 | Up to 90% of patients with dementia have behavioral and psychological symptoms of dementia (BPSD), and agitation is the most common among these behavioral disturbances. These symptoms have detrimental effects on patients with dementia and their caregivers. If not managed well, these neuropsychiatric symptoms may lead to accelerated cognitive and functional decline, early institutionalization, or increased mortality. Unfortunately, many psychotropic medications for treating agitation are associated with adverse events. Out of safety concerns, the US Food and Drug Administration and the European Medicines Agency issued warnings on antipsychotic prescriptions for dementia. However, some evidence showed that, while antipsychotic use might be reduced, alternative psychotropic prescriptions might increase. Aged care homes around the world have conducted studies aiming to decrease psychotropic prescriptions in recent years. These studies adopted different intervention components, and the outcomes were not identical. For example, more evidence supports that multi-component approaches achieved better results than medication review interventions alone could. In this article, we will review these issues and make suggestions based on the latest evidence and guidelines for clinicians to consider in daily practice. |
本系統中英文摘要資訊取自各篇刊載內容。